The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis

Show other versions (2)

Bibliographic Details
Main Authors:	Clark, W, Jobanputra, P, Barton, P, Burls, A
Format:	Journal article
Published:	2004

Similar Items

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
by: Clark, W, et al.
Published: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
by: Clark, W, et al.
Published: (2004)

The trials of anakinra.
by: Burls, A, et al.
Published: (2004)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
by: Chen, Y, et al.
Published: (2006)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
by: Chen, Y, et al.
Published: (2006)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
by: Jobanputra, P, et al.
Published: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
by: Jobanputra, P, et al.
Published: (2002)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
by: Ruiz Garcia, V, et al.
Published: (2014)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
by: Ruiz Garcia, V, et al.
Published: (2011)

A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.
by: Jobanputra, P, et al.
Published: (2004)

Etanercept for the treatment of rheumatoid arthritis.
by: Lethaby, A, et al.
Published: (2013)

Infliximab for the treatment of rheumatoid arthritis.
by: Blumenauer, B, et al.
Published: (2002)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
by: Barton, P, et al.
Published: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
by: Barton, P, et al.
Published: (2004)

Etanercept for the treatment of rheumatoid arthritis.
by: Blumenauer, B, et al.
Published: (2003)

Etanercept for the treatment of rheumatoid arthritis
by: Blumenauer, B, et al.
Published: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction
by: Barton, P, et al.
Published: (2004)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
by: Burls, A, et al.
Published: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
by: Burls, A, et al.
Published: (2002)

Leflunomide and rheumatoid arthritis: a systematic review of effectiveness, safety and cost implications
by: Hewitson, P, et al.
Published: (2001)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Rituximab in the treatment of rheumatoid arthritis.
by: Taylor, P
Published: (2007)

Filgotinib for the treatment of rheumatoid arthritis
by: Taylor, P, et al.
Published: (2017)

Treatment of vasculitis in rheumatoid arthritis.
by: Luqmani, R, et al.
Published: (1994)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
by: Cummins, C, et al.
Published: (2002)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
by: Cummins, C, et al.
Published: (2002)

Clinical features of rheumatoid arthritis
by: Colquhoun, M, et al.
Published: (2022)

Infliximab and methotrexate in the treatment of rheumatoid arthritis
by: Lipsky, P, et al.
Published: (2000)

Anti-cytokines and cytokines in the treatment of rheumatoid arthritis.
by: Taylor, P
Published: (2003)

Role of biological agents in treatment of rheumatoid arthritis
by: Law, S, et al.
Published: (2019)

Rheumatoid arthritis
by: Taylor, P
Published: (2022)

Rheumatoid arthritis.
by: Wordsworth, P
Published: (1992)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
by: Stewart, A, et al.
Published: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: A rapid and systematic review
by: Stewart, A, et al.
Published: (2001)

A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis
by: Boniface, G, et al.
Published: (2020)

A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2011)

Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis
by: Taylor, P
Published: (2019)

Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes
by: Lewis, MJ, et al.
Published: (2019)

Erratum to: A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis.
by: Taylor, P, et al.
Published: (2012)